• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后女性的孕激素激发试验:临床与形态学方面

The progestogen challenge test in postmenopausal women: clinical and morphologic aspects.

作者信息

Bortoletto C de C, Baracat E C, Gonçalves W J, Stávalle J N, de Lima G R, Novo N F

机构信息

Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil.

出版信息

Sao Paulo Med J. 1996 May-Jun;114(3):1166-72. doi: 10.1590/s1516-31801996000300005.

DOI:10.1590/s1516-31801996000300005
PMID:9181748
Abstract

The clinical aspects and anatomopathological patterns of 150 postmenopausal women were studied using the progestogen challenge test. An endometrial biopsy was obtained and submitted to the progestogen test. A histopathological analysis of the uterine mucosa from women with a positive progestogen test revealed that the endometrium was active in 44 percent of cases and atrophic or inactive in 56 percent. In contrast, among women with a negative response, the endometrium was atrophic in 94 percent of cases and active in 6 percent. Analysis of clinical aspects did not show significant differences between groups in terms of age; age at menarche and at menopause; fasting blood glucose levels; or body mass. However, postmenopausal time was significantly shorter for women with a positive test, with a correlation between postmenopausal time of one to two years and test positivity. The progestogen challenge test for the detection of atrophic endometrium presented 78.57 percent sensitivity, 77.05 percent specificity, 44 percent positive predictive value, and 94 percent negative predictive value. Thus, when negative, the test is highly valuable, indicating the presence of atrophic endometrium in 94 percent of cases. False-negative results occurred in only 6 percent of the subjects, with no case of hyperplasia detected. However, when the response to the test was positive, the endometrium was atrophic in 56 percent of the cases. We suggest that, in order to avoid invasive procedures, the progestogen challenge test be combined with other methods such as transvaginal ultrasonography.

摘要

采用孕激素激发试验对150名绝经后女性的临床情况和解剖病理学模式进行了研究。获取子宫内膜活检样本并进行孕激素试验。对孕激素试验呈阳性的女性的子宫黏膜进行组织病理学分析发现,44%的病例子宫内膜呈活跃状态,56%呈萎缩或不活跃状态。相比之下,在反应呈阴性的女性中,94%的病例子宫内膜呈萎缩状态,6%呈活跃状态。临床情况分析显示,两组在年龄、初潮年龄和绝经年龄、空腹血糖水平或体重方面无显著差异。然而,试验呈阳性的女性绝经时间明显较短,绝经时间在1至2年与试验阳性之间存在相关性。用于检测萎缩性子宫内膜的孕激素激发试验的灵敏度为78.57%,特异度为77.05%,阳性预测值为44%,阴性预测值为94%。因此,当试验结果为阴性时,该试验具有很高的价值,表明94%的病例存在萎缩性子宫内膜。仅6%的受试者出现假阴性结果,未检测到增生病例。然而,当试验反应为阳性时,56%的病例子宫内膜呈萎缩状态。我们建议,为避免侵入性操作,孕激素激发试验应与经阴道超声检查等其他方法联合使用。

相似文献

1
The progestogen challenge test in postmenopausal women: clinical and morphologic aspects.绝经后女性的孕激素激发试验:临床与形态学方面
Sao Paulo Med J. 1996 May-Jun;114(3):1166-72. doi: 10.1590/s1516-31801996000300005.
2
Transvaginal ultrasonography and the progestogen challenge test in postmenopausal endometrial evaluation.经阴道超声检查及孕激素激发试验在绝经后子宫内膜评估中的应用
Int J Gynaecol Obstet. 1997 Sep;58(3):293-8. doi: 10.1016/s0020-7292(97)00111-2.
3
Endometrial response in estrogen replacement therapy quarterly combined with a progestogen.雌激素替代疗法联合孕激素每季度应用时的子宫内膜反应。
Maturitas. 1996 May;24(1-2):63-71. doi: 10.1016/0378-5122(95)01020-3.
4
Comparison of transvaginal ultrasonography and endometrial biopsy in endometrial surveillance in postmenopausal HRT users.经阴道超声检查与子宫内膜活检在绝经后激素替代治疗使用者子宫内膜监测中的比较。
Maturitas. 1997 Jun;27(2):133-43. doi: 10.1016/s0378-5122(97)00037-6.
5
The role of hysteroscopy with eye-directed biopsy in postmenopausal women with uterine bleeding and endometrial atrophy.宫腔镜直视下活检在绝经后子宫出血和子宫内膜萎缩女性中的作用。
Menopause. 2008 Jul-Aug;15(4 Pt 1):737-42. doi: 10.1097/gme.0b013e31815b644e.
6
Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.孕激素检测在接受他莫昔芬治疗的无症状绝经后妇女的子宫内膜病理筛查中的价值。
Menopause. 2010 May-Jun;17(3):487-93.
7
Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.接受孕激素治疗的绝经后女性子宫内膜癌发病率降低。
J Am Geriatr Soc. 1979 Sep;27(9):389-94. doi: 10.1111/j.1532-5415.1979.tb01673.x.
8
Screening transvaginal uterine ultrasonography for identifying endometrial pathology in postmenopausal women.经阴道子宫超声检查用于绝经后女性子宫内膜病变的筛查。
Anticancer Res. 2002 Jul-Aug;22(4):2517-20.
9
Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding.宫腔镜检查联合子宫内膜活检在绝经后异常子宫出血女性中排除子宫内膜癌的作用。
Maturitas. 2005 Feb 14;50(2):117-23. doi: 10.1016/j.maturitas.2004.05.003.
10
Transvaginal hysterosonography: comparison with biopsy in the evaluation of postmenopausal bleeding.经阴道子宫超声检查:与活检在绝经后出血评估中的比较。
J Ultrasound Med. 1995 Dec;14(12):887-93. doi: 10.7863/jum.1995.14.12.887.